Bolton Securities’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Sell
1,205
-3
-0.2% -$602 0.01% 809
2026
Q2
$230K Sell
1,208
-32,580
-96% -$5.6M 0.01% 861
2026
Q1
$5.71M Buy
33,788
+1,030
+3% +$176K 0.27% 79
2025
Q4
$5.53M Sell
32,758
-86
-0.3% -$14K 0.26% 83
2025
Q3
$4.74M Buy
32,844
+14,716
+81% +$2.01M 0.22% 110
2025
Q2
$2.29M Buy
18,128
+17,275
+2,025% +$2.12M 0.12% 195
2025
Q1
$109K Buy
+853
New +$116K 0.01% 846

Other funds holding IBB

Bolton Securities's IBB Position: Q3 2026 in Review

Bolton Securities reduced its iShares Biotechnology ETF (IBB) stake by 0.25% in Q3 2026, selling an estimated $602 and leaving 1,205 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #809.

Bolton Securities first reported a position in IBB in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.71M in Q1 2026. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Bolton Securities held 1,205 shares of iShares Biotechnology ETF worth $254K as of Q3 2026.
  • Bolton Securities sold 3 iShares Biotechnology ETF shares in Q3 2026, an estimated $602.
  • iShares Biotechnology ETF made up 0.01% of Bolton Securities's portfolio in Q3 2026, its #809 holding.
  • Bolton Securities first reported a position in iShares Biotechnology ETF in Q1 2025 and has held it in 7 quarters since.
  • Bolton Securities's iShares Biotechnology ETF position peaked at $5.71M in Q1 2026.
  • 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.